Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew M Laughon

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
The Journal of Pediatrics|February 17, 2012
Feasibility study of early blood pressure management in extremely preterm infantsBeau J Batton, Lei Li, Nancy S Newman, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2019
The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based ApproachErik A Jensen, Kevin Dysart, Marie G Gantz, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|January 25, 2022
Association between postmenstrual age and furosemide dosing practices in very preterm infantsNicolas A Bamat, Elizabeth J Thompson, Rachel G Greenberg, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2016
Clindamycin Pharmacokinetics and Safety in Preterm and Term InfantsDaniel Gonzalez, Paula Delmore, Barry T Bloom, et al.
The Journal of Pediatrics|September 3, 2018
Association of Atrial Septal Defects and Bronchopulmonary Dysplasia in Premature InfantsKaran R Kumar, David A Clark, Evan M Kim, et al.
British Journal of Clinical Pharmacology|September 3, 2019
Population pharmacokinetics of sildenafil in extremely premature infantsDaniel Gonzalez, Matthew M Laughon, P Brian Smith, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|November 6, 2021
Safety of sildenafil in extremely premature infants: a phase I trialWesley Jackson, Daniel Gonzalez, P Brian Smith, et al.
JAMA Network Open|May 8, 2023
Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm InfantsErik A Jensen, Laura Elizabeth Wiener, Matthew A Rysavy, et al.
BMJ Open|August 26, 2025
Evaluating the efficacy and safety of milrinone for prevention of post-patent ductus arteriosus closure syndrome (the MIDAS trial) in extremely preterm infants: a multicentre, double-masked, randomised, placebo-controlled trialPatrick J McNamara, Valerie Y Chock, Adrianne Rahde-Bischoff, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2025
Metronidazole exposure-response and safety in infantsRachel L Randell, Stephen J Balevic, Rachel G Greenberg, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
The Journal of Pediatrics|February 17, 2012
Feasibility study of early blood pressure management in extremely preterm infantsBeau J Batton, Lei Li, Nancy S Newman, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2019
The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based ApproachErik A Jensen, Kevin Dysart, Marie G Gantz, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|January 25, 2022
Association between postmenstrual age and furosemide dosing practices in very preterm infantsNicolas A Bamat, Elizabeth J Thompson, Rachel G Greenberg, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2016
Clindamycin Pharmacokinetics and Safety in Preterm and Term InfantsDaniel Gonzalez, Paula Delmore, Barry T Bloom, et al.
The Journal of Pediatrics|September 3, 2018
Association of Atrial Septal Defects and Bronchopulmonary Dysplasia in Premature InfantsKaran R Kumar, David A Clark, Evan M Kim, et al.
British Journal of Clinical Pharmacology|September 3, 2019
Population pharmacokinetics of sildenafil in extremely premature infantsDaniel Gonzalez, Matthew M Laughon, P Brian Smith, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|November 6, 2021
Safety of sildenafil in extremely premature infants: a phase I trialWesley Jackson, Daniel Gonzalez, P Brian Smith, et al.
JAMA Network Open|May 8, 2023
Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm InfantsErik A Jensen, Laura Elizabeth Wiener, Matthew A Rysavy, et al.
BMJ Open|August 26, 2025
Evaluating the efficacy and safety of milrinone for prevention of post-patent ductus arteriosus closure syndrome (the MIDAS trial) in extremely preterm infants: a multicentre, double-masked, randomised, placebo-controlled trialPatrick J McNamara, Valerie Y Chock, Adrianne Rahde-Bischoff, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2025
Metronidazole exposure-response and safety in infantsRachel L Randell, Stephen J Balevic, Rachel G Greenberg, et al.
Pageof 11